Summary
Updated Aug 31, 2026
Todd S. Thomson is Director, 10% Owner of ACTUATE THERAPEUTICS, INC. (ACTU). 3 SEC Form 4 filings on record going back to 2025, most recently on 22 May 2026. Most recent open-market trade: sold $1.62M of ACTU on 7 January 2026. Lifetime open-market sales: $1.62M.
Recent Transactions
1Every recent SEC Form 4 transaction Todd S. Thomson has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Todd S. Thomson's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mark J. Tarr - $38.47M of EHC open-market activity in the last 12 months
- Helen Torley - $37.86M of HALO open-market activity in the last 12 months
- Kevin Charles Gorman - $37.82M of NBIX open-market activity in the last 12 months
- Emily M. Leproust - $35.18M of TWST open-market activity in the last 12 months
- Tactic Pharma LLC - $35.00M of MNPR open-market activity in the last 12 months
- Roelof Botha - $34.89M of NTRA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Todd S. Thomson?
Todd S. Thomson is a corporate insider, tracked as Director, 10% Owner of ACTUATE THERAPEUTICS, INC. (ACTU). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Todd S. Thomson last file a Form 4?
The most recent primary Form 4 on record is dated 22 May 2026, one of 3 filings going back to 2025.
Has Todd S. Thomson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($1.62M) across all tracked filings.
Where can I see all of Todd S. Thomson's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Todd S. Thomson and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
